Should Salvage Surgery Be Considered for Local Recurrence After Definitive Chemoradiation in Locally Advanced Non-small Cell Lung Cancer?

Overview

Journal J Cardiothorac Surg

Publisher Biomed Central

Specialties Cardiology & Vascular Diseases
General Surgery
Pulmonary Medicine

Date 2016 Jan 20

PMID 26781697

Citations 10

Authors

Waldemar Schreiner

Wojciech Dudek

Sebastian Lettmaier

Rainer Fietkau

Horia Sirbu

Affiliations

Soon will be listed here.

Abstract

Background: Incidence of local relapse after definitive chemoradiation (>59 Gy) for locally advanced non-small-cell lung cancer (NSCLC) is high, irrespective of high dose radiation applied. Experience with salvage lung resections in patients with locally relapsed NSCLC after definitive chemoradiation is limited. We present our series of salvage lung resections for local NSCLC relapse after curative-intent chemoradiation for locally advanced tumor.

Methods: Nine consecutive patients with local tumor recurrence or persistence following definitive chemoradiation were reviewed. Kaplan-Meier analysis was used to assess patient survival.

Results: All patients received definitive radiation (median dose 66.2 Gy) with concurrent chemotherapy. Tumor stage prior to chemoradiation was IIIA in 8 patients and IV in 1. In 4 patients tumor invaded the chest wall, in 2 the spine and in 1 the aorta. Median interval between chemoradiation and salvage resection was 30.2 weeks. Nine patients underwent 9 resections (6 lobectomies, 1 bilobectomy, 1 pneumonectomy and 1 bi-segmentectomy). One death occurred on the 12th postoperative day. Median overall survival was 23 months; postoperative 3-year survival was 47 %. Median progression-free survival was 21 months.

Conclusion: Salvage lung resection for locally recurrent or persisted NSCLC in selected patients with locally advanced NSCLC following definitive chemoradiation is a worthwhile treatment option.

Citing Articles

Salvage lung resection after immunotherapy is feasible and safe.

Nemeth A, Canavan M, Zhan P, Udelsman B, Ely S, Wigle D JTCVS Open. 2024; 20:141-150.

PMID: 39296459 PMC: 11405986. DOI: 10.1016/j.xjon.2024.03.018.

Reduction of Blood Loss by Means of the Cavitron Ultrasonic Surgical Aspirator for Thoracoscopic Salvage Anatomic Lung Resections.

Wang Y, Tsai S, Lin F Cancers (Basel). 2023; 15(16).

PMID: 37627096 PMC: 10452171. DOI: 10.3390/cancers15164069.

Results of emergency salvage lung resection after chemo- and/or radiotherapy among patients with lung cancer.

Hino H, Utsumi T, Maru N, Matsui H, Taniguchi Y, Saito T Interact Cardiovasc Thorac Surg. 2022; 35(1).

PMID: 35253874 PMC: 9714598. DOI: 10.1093/icvts/ivac043.

Salvage surgery after definitive chemoradiotherapy through VATS for an initial unresectable locally advanced lung cancer: an alternative consolidative modality to radiotherapy?.

Yu H, Chen Y, Yeh Y, Huang C, Chiu C Surg Case Rep. 2021; 7(1):138.

PMID: 34101076 PMC: 8187677. DOI: 10.1186/s40792-021-01227-2.

Pattern-of-failure and salvage treatment analysis after chemoradiotherapy for inoperable stage III non-small cell lung cancer.

Taugner J, Eze C, Kasmann L, Roengvoraphoj O, Gennen K, Karin M Radiat Oncol. 2020; 15(1):148.

PMID: 32517716 PMC: 7285541. DOI: 10.1186/s13014-020-01590-8.

References

Jeremic B, Videtic G . Chest reirradiation with external beam radiotherapy for locally recurrent non-small-cell lung cancer: a review. Int J Radiat Oncol Biol Phys. 2011; 80(4):969-77. DOI: 10.1016/j.ijrobp.2011.01.069. View

Allibhai Z, Cho B, Taremi M, Atallah S, Hope A, Hwang D . Surgical salvage following stereotactic body radiotherapy for early-stage NSCLC. Eur Respir J. 2012; 39(4):1039-42. DOI: 10.1183/09031936.00075811. View

Glynne-Jones R, Hughes R . Critical appraisal of the 'wait and see' approach in rectal cancer for clinical complete responders after chemoradiation. Br J Surg. 2012; 99(7):897-909. DOI: 10.1002/bjs.8732. View

Goto T, Izumi Y, Nakatsuka S, Nomori H . Percutaneous cryoablation as a salvage therapy for local recurrence of lung cancer. Ann Thorac Surg. 2012; 94(2):e31-3. DOI: 10.1016/j.athoracsur.2012.01.090. View

Schoellnast H, Deodhar A, Hsu M, Moskowitz C, Nehmeh S, Thornton R . Recurrent non-small cell lung cancer: evaluation of CT-guided radiofrequency ablation as salvage therapy. Acta Radiol. 2012; 53(8):893-9. DOI: 10.1258/ar.2012.110333. View

Kuzmik G, Detterbeck F, Decker R, Boffa D, Wang Z, Oliva I . Pulmonary resections following prior definitive chemoradiation therapy are associated with acceptable survival. Eur J Cardiothorac Surg. 2013; 44(1):e66-70. DOI: 10.1093/ejcts/ezt184. View

Habr-Gama A, Gama-Rodrigues J, Sao Juliao G, Proscurshim I, Sabbagh C, Lynn P . Local recurrence after complete clinical response and watch and wait in rectal cancer after neoadjuvant chemoradiation: impact of salvage therapy on local disease control. Int J Radiat Oncol Biol Phys. 2014; 88(4):822-8. DOI: 10.1016/j.ijrobp.2013.12.012. View

Uramoto H, Tanaka F . Salvage thoracic surgery in patients with primary lung cancer. Lung Cancer. 2014; 84(2):151-5. DOI: 10.1016/j.lungcan.2014.02.004. View

Taira N, Kawabata T, Ichi T, Kushi K, Yohena T, Kawasaki H . Salvage operation for late recurrence after stereotactic body radiotherapy for lung cancer: two patients with no viable cancer cells. Ann Thorac Surg. 2014; 97(6):2167-71. DOI: 10.1016/j.athoracsur.2013.07.123. View

10.

McAvoy S, Ciura K, Wei C, Rineer J, Liao Z, Chang J . Definitive reirradiation for locoregionally recurrent non-small cell lung cancer with proton beam therapy or intensity modulated radiation therapy: predictors of high-grade toxicity and survival outcomes. Int J Radiat Oncol Biol Phys. 2014; 90(4):819-27. DOI: 10.1016/j.ijrobp.2014.07.030. View

11.

Raptis D, Schneider I, Matzel K, Ott O, Fietkau R, Hohenberger W . The differential diagnosis and interdisciplinary treatment of anal carcinoma. Dtsch Arztebl Int. 2015; 112(14):243-9. PMC: 4413245. DOI: 10.3238/arztebl.2015.0243. View

12.

Yang C, Meyerhoff R, Stephens S, Singhapricha T, Toomey C, Anderson K . Long-Term Outcomes of Lobectomy for Non-Small Cell Lung Cancer After Definitive Radiation Treatment. Ann Thorac Surg. 2015; 99(6):1914-20. PMC: 4458187. DOI: 10.1016/j.athoracsur.2015.01.064. View

13.

Okamoto Y, Murakami M, Yoden E, Sasaki R, Okuno Y, Nakajima T . Reirradiation for locally recurrent lung cancer previously treated with radiation therapy. Int J Radiat Oncol Biol Phys. 2002; 52(2):390-6. DOI: 10.1016/s0360-3016(01)02644-x. View

14.

Neri S, Takahashi Y, Terashi T, Hamakawa H, Tomii K, Katakami N . Surgical treatment of local recurrence after stereotactic body radiotherapy for primary and metastatic lung cancers. J Thorac Oncol. 2010; 5(12):2003-7. DOI: 10.1097/JTO.0b013e3181f8a785. View

15.

Chen F, Matsuo Y, Yoshizawa A, Sato T, Sakai H, Bando T . Salvage lung resection for non-small cell lung cancer after stereotactic body radiotherapy in initially operable patients. J Thorac Oncol. 2010; 5(12):1999-2002. DOI: 10.1097/JTO.0b013e3181f260f9. View

16.

Van Schil P . Salvage surgery after stereotactic radiotherapy: a new challenge for thoracic surgeons. J Thorac Oncol. 2010; 5(12):1881-2. DOI: 10.1097/JTO.0b013e3181fad91a. View

17.

Bradley J . New territory: surgical salvage for stereotactic body radiation therapy failures in lung cancer. J Thorac Oncol. 2010; 5(12):1879-80. DOI: 10.1097/JTO.0b013e318200dea6. View

18.

Hanna N . Second-line treatment of non-small cell lung cancer: big targets, small progress; small targets, big progress?. J Thorac Oncol. 2007; 1(9):927-8. View

19.

Auperin A, Le Pechoux C, Rolland E, Curran W, Furuse K, Fournel P . Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer. J Clin Oncol. 2010; 28(13):2181-90. DOI: 10.1200/JCO.2009.26.2543. View

20.

Fietkau R, Semrau S . Stage III: definitive chemoradiotherapy. Front Radiat Ther Oncol. 2009; 42:122-134. DOI: 10.1159/000262467. View